Medical Device and Diagnostics
News & Jobs
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login  
Medical Device Companies | Diagnostic Companies | Organizations | Search Profiles
 Company Profile


Asuragen, Inc. 

2150 Woodward Street
Suite 100
Austin  Texas  78744  U.S.A.
Phone: 512-651-0191 Fax: 512-721-4859


 Company News
Asuragen, Inc. To Present Innovations In Fragile X Testing At Upcoming American College Of Medical Genetics And Genomics (ACMG) Annual Clinical Genetics Meeting 3/24/2015 12:20:14 PM
Asuragen, Inc. To Join Leading UK Cancer Research Consortium To Develop Mirna Based Sequencing Tests For Early Detection And Screening Of Cancer 1/12/2015 11:09:08 AM
Asuragen, Inc. Launches The Quantidex™ DNA Assay To Improve The Accuracy Of Next-Generation Sequencing 11/11/2014 11:10:37 AM
Asuragen, Inc. To Present At Upcoming Association For Molecular Pathology Annual Meeting In National Harbor, MD 11/11/2014 9:38:33 AM
Asuragen, Inc.’s Xpansion Interpreter® Test Study Of 1,040 Transmissions Of Fragile X Alleles Reveals Personalized Risks For Expansion From Parent To Child 9/17/2014 11:03:45 AM
Company Profile For Asuragen, Inc. 8/15/2014 10:44:49 AM
Asuragen, Inc. Names Matthew McManus, M.D., Ph.D., President And CEO 8/5/2014 10:26:29 AM
Asuragen, Inc. Receives New York State License For Molecular Genetic And Oncology Clinical Laboratory Testing 7/10/2014 6:20:01 AM
Asuragen, Inc. Receives Notice of Patent Allowance for Broad Diagnostic Application of miR-21 in Cancer 10/8/2013 10:08:52 AM
Exiqon A/S and Asuragen, Inc. Sign Agreement for Real-Time PCR Services 6/10/2013 9:38:14 AM